2 research outputs found
Discovery of Potent and Highly Selective A<sub>2B</sub> Adenosine Receptor Antagonist Chemotypes
Three novel families of A<sub>2B</sub> adenosine receptor antagonists
were identified in the context of the structural exploration of the
3,4-dihydropyrimidin-2(1<i>H</i>)-one chemotype. The most
appealing series contain imidazole, 1,2,4-triazole, or benzimidazole
rings fused to the 2,3-positions of the parent diazinone core. The
optimization process enabled identification of a highly potent (3.49
nM) A<sub>2B</sub> ligand that exhibits complete selectivity toward
A<sub>1</sub>, A<sub>2A</sub>, and A<sub>3</sub> receptors. The results
of functional cAMP experiments confirmed the antagonistic behavior
of representative ligands. The main SAR trends identified within the
series were substantiated by a molecular modeling study based on a
receptor-driven docking model constructed on the basis of the crystal
structure of the human A<sub>2A</sub> receptor
Discovery of Potent and Highly Selective A<sub>2B</sub> Adenosine Receptor Antagonist Chemotypes
Three novel families of A<sub>2B</sub> adenosine receptor antagonists
were identified in the context of the structural exploration of the
3,4-dihydropyrimidin-2(1<i>H</i>)-one chemotype. The most
appealing series contain imidazole, 1,2,4-triazole, or benzimidazole
rings fused to the 2,3-positions of the parent diazinone core. The
optimization process enabled identification of a highly potent (3.49
nM) A<sub>2B</sub> ligand that exhibits complete selectivity toward
A<sub>1</sub>, A<sub>2A</sub>, and A<sub>3</sub> receptors. The results
of functional cAMP experiments confirmed the antagonistic behavior
of representative ligands. The main SAR trends identified within the
series were substantiated by a molecular modeling study based on a
receptor-driven docking model constructed on the basis of the crystal
structure of the human A<sub>2A</sub> receptor